不同亚表型ARDS患者对呼气末正压策略的差异反应:一项贝叶斯分析
该研究基于ALVEOLI和ART两项比较不同PEEP策略的ARDS试验数据,纳入1559例成人ARDS患者,按先前描述的9项常规临床变量分为两种亚表型,采用贝叶斯分层logistic模型评估PEEP策略对28天死亡率的差异效应。结果显示,与较低PEEP相比,较高PEEP在亚表型A患者中28天死亡率更高(ALVEOLI研究OR 1.61,95%可信区间0.90-2.94;ART研究OR 1.73,95%可信区间1.01-2.98),较高PEEP导致伤害的概率分别为94.3%和97.7%。在亚表型B患者中,较高PEEP与死亡率无显著关联(ALVEOLI研究OR 0.95,95%可信区间0.51-1.73;ART研究OR 1.00,95%可信区间0.63-1.55),获益概率分别为56.4%和50.7%。这些效应未受到氧合指数、驱动压或疾病严重程度的影响。作者认为,该发现提示较高PEEP策略在一个亚表型中可能存在伤害,可能有助于未来临床试验的预测性富集。
要点
- 在亚表型A的ARDS患者中,较高PEEP策略与28天死亡率升高相关(ALVEOLI研究OR 1.61,95%可信区间0.90-2.94;ART研究OR 1.73,95%可信区间1.01-2.98),较高PEEP导致伤害的概率分别为94.3%和97.7%。
- 在亚表型B的ARDS患者中,较高PEEP与28天死亡率无显著关联(ALVEOLI研究OR 0.95,95%可信区间0.51-1.73;ART研究OR 1.00,95%可信区间0.63-1.55),获益概率分别为56.4%和50.7%。
- PEEP策略的效应未受到氧合指数、驱动压或疾病严重程度的影响。
- 作者认为,该发现提示较高PEEP策略在一个亚表型中可能存在伤害,可能有助于未来临床试验的预测性富集。
适用人群与场景
- 成人ARDS患者,数据来自ALVEOLI和ART两项试验。
- 按先前描述的9项常规临床变量分为两种亚表型(亚表型A和亚表型B)。
研究设计与关键结果
- 研究类型:对ALVEOLI和ART两项试验数据的贝叶斯分析;样本量1559例ARDS患者;干预为较高PEEP策略 vs 较低PEEP策略;主要终点为28天死亡率。
- 亚表型A:较高PEEP vs 较低PEEP的28天死亡率OR在ALVEOLI研究为1.61(95%可信区间0.90-2.94),在ART研究为1.73(95%可信区间1.01-2.98);较高PEEP导致伤害的概率分别为94.3%和97.7%。
- 亚表型B:较高PEEP vs 较低PEEP的28天死亡率OR在ALVEOLI研究为0.95(95%可信区间0.51-1.73),在ART研究为1.00(95%可信区间0.63-1.55);较高PEEP获益的概率分别为56.4%和50.7%。
- 效应修饰:上述效应未受到氧合指数、驱动压或疾病严重程度的影响。
证据类型、等级与局限
- 证据类型:基于两项随机对照试验(ALVEOLI和ART)数据的贝叶斯分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该发现提示较高PEEP策略在亚表型A患者中可能存在伤害,在亚表型B患者中未观察到显著关联;这些观察可能有助于未来临床试验的预测性富集。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: ARDS is a heterogeneous condition with two subphenotypes identified by different methodologies. Our group similarly identified two ARDS subphenotypes using nine routinely available clinical variables. However, whether these are associated with differential response to treatment has yet to be explored.
RESEARCH QUESTION: Are there differential responses to positive end-expiratory pressure (PEEP) strategies on 28-day mortality according to subphenotypes in adult patients with ARDS?
STUDY DESIGN AND METHODS: We evaluated data from two prior ARDS trials (Higher vs Lower Positive End-Expiratory Pressures in Patients With the ARDS [ALVEOLI] and the Alveolar Recruitment in ARDS Trial [ART]) that compared different PEEP strategies. We classified patients into one of two subphenotypes as described previously. We assessed the differential effect of PEEP with a Bayesian hierarchical logistic model for the primary outcome of 28-day mortality.
RESULTS: We analyzed data from 1,559 patients with ARDS. Compared with lower PEEP, a higher PEEP strategy resulted in higher 28-day mortality in patients with subphenotype A disease in the ALVEOLI study (OR, 1.61; 95% credible interval [CrI], 0.90-2.94) and ART (OR, 1.73; 95% CrI, 1.01-2.98), with a probability of harm resulting from higher PEEP in this subphenotype of 94.3% and 97.7% in the ALVEOLI and ART studies, respectively. Higher PEEP was not associated with mortality in patients with subphenotype B disease in each trial (OR, 0.95 [95% CrI, 0.51-1.73] and 1.00 [95% CrI, 0.63-1.55], respectively), with probability of benefit of 56.4% and 50.7% in the ALVEOLI and ART studies, respectively. These effects were not modified by Pao2 to Fio2 ratio, driving pressure, or the severity of illness for the cohorts.
INTERPRETATION: We found evidence of differential response to PEEP strategies across two ARDS subphenotypes, suggesting possible harm with a higher PEEP strategy in one subphenotype. These observations may assist with predictive enrichment in future clinical trials.
参考来源
- Siuba MT, Bulgarelli L, Duggal A, et al. Differential Effect of Positive End-Expiratory Pressure Strategies in Patients With ARDS: A Bayesian Analysis of Clinical Subphenotypes. Chest. 2024. PMID: 38768777. doi:10.1016/j.chest.2024.04.011
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。